Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMARIN CORP PLC\UKAMRN · Entity 5970 | Director | January 10, 2023 | February 24, 2023 |
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | May 06, 2021 | May 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMARIN CORP PLC\UK
Report date January 10, 2023 · Filed February 24, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 171,027 |
Reported balance
After 2023-01-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-01-10 · Exercise / conversion · Acquired 22,027 · Balance 171,027 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2: On January 10, 2022, the Reporting Person was granted 81,082 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the anniversary of the grant date of January 10, 2022. F3: Not applicable. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 59,055 |
Reported balance
After 2023-01-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-10 · Exercise / conversion · Disposed 22,027 · Balance 59,055 F4: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2: On January 10, 2022, the Reporting Person was granted 81,082 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the anniversary of the grant date of January 10, 2022. F3: Not applicable. F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2: On January 10, 2022, the Reporting Person was granted 81,082 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the anniversary of the grant date of January 10, 2022.
F3: Not applicable.
F4: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
GILEAD SCIENCES, INC.
Report date May 06, 2021 · Filed May 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,060 |
Reported balance
After 2021-05-06 transaction · row 1
1 source rowRow 1 · 2021-05-06 · Exercise / conversion · Acquired 1,936 · Balance 102,060 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-05-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-06 · Exercise / conversion · Disposed 1,936 · Balance 0 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: 100% of the restricted stock units vested on May 6, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: 100% of the restricted stock units vested on May 6, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2023 Filed Feb 24, 2023 02:56 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 22,027 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-006081 · doc4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,055 Underlying: Ordinary Shares · 22,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On January 10, 2022, the Reporting Person was granted 81,082 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the anniversary of the grant date of January 10, 2022. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 10, 2023 Filed Feb 24, 2023 02:56 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 22,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-006081 · doc4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On January 10, 2022, the Reporting Person was granted 81,082 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the anniversary of the grant date of January 10, 2022. F3 · price: Not applicable. Read SEC document |
| June 27, 2022 Filed Jun 30, 2022 00:04 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 98,959 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005401 · primarydocument.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,959 Underlying: Ordinary Shares · 98,959 shares Expires not disclosed F3 · security: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. F4 · derivative.exercise_date: On June 27, 2022, the Reporting Person was granted 98,959 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in such year. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 27, 2022 Filed Jun 30, 2022 00:04 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 122,359 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001562180-22-005401 · primarydocument.xml · derivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,359 Underlying: Ordinary Shares · 122,359 shares Expires 2032-06-27 F1 · derivative.exercise_date: On June 27, 2022, the Reporting Person was granted an option to purchase 122,359 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 27, 2022 or (ii) the Issuer's annual general meeting of shareholders in 2023. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 13, 2022 Filed Jun 16, 2022 00:01 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | PurchaseOrdinary Shares | 55,000 | $1.69 | $92,730.00 |
DisclosureSEC source: 0001562180-22-005127 · primarydocument.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,000 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.70, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares purchased at each separate price. F3 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 10, 2022 Filed Jan 14, 2022 01:02 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 81,082 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000467 · primarydocument.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,082 Underlying: Ordinary Shares · 81,082 shares Expires not disclosed F3 · security: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F4 · derivative.exercise_date: On January 10, 2022, the Reporting Person was granted 81,082 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the anniversary of the grant date of January 10, 2022. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 10, 2022 Filed Jan 14, 2022 01:02 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 103,569 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001562180-22-000467 · primarydocument.xml · derivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,569 Underlying: Ordinary Shares · 103,569 shares Expires 2032-01-10 F1 · derivative.exercise_date: On January 10, 2022, the Reporting Person was granted an option to purchase 103,569 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the one-year anniversary of the grant date of January 10, 2022. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| May 06, 2021 Filed May 7, 2021 23:02 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-015956 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 6, 2021. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 6, 2021. Read SEC document |
| May 06, 2021 Filed May 7, 2021 23:02 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-015956 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 06, 2020 Filed May 8, 2020 00:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,886 | $0.00 Strike: $77.47 | $0.00 |
DisclosureSEC source: 0001127602-20-015842 · form4.xml · derivative · entry 4 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,886 Underlying: Common Stock · 7,886 shares Expires 2030-05-06 F4 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 6, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2020 Filed May 8, 2020 00:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015842 · form4.xml · derivative · entry 3 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,936 Underlying: Common Stock · 1,936 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 2,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015842 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 5, 2020. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 5, 2020. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015842 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 23:25 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 20,282 | $0.00 Strike: $20.65 | $0.00 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · derivative · entry 6 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,282 shares Expires 2021-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 12, 2012. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 23:25 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 20,282 | $69.00 | $1,399,458.00 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · nonDerivative · entry 4 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,854 Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 23:25 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 20,282 | $20.65 | $418,721.89 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · nonDerivative · entry 3 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:25 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 21,720 | $0.00 Strike: $19.63 | $0.00 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · derivative · entry 5 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,720 shares Expires 2020-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 11, 2011. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:25 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 21,720 | $68.12 | $1,479,605.50 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · nonDerivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,854 F1 · price: Sale prices reported for the transactions reported here range from $68.1000 to $68.1750. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:25 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 21,720 | $19.63 | $426,363.60 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2019 Filed Aug 29, 2019 20:42 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 4,908 | $0.00 Strike: $23.76 | $0.00 |
DisclosureSEC source: 0001127602-19-027574 · form4.xml · derivative · entry 3 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,908 shares Expires 2020-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on January 28, 2011. Read SEC document |
| August 28, 2019 Filed Aug 29, 2019 20:42 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 4,908 | $63.91 | $313,670.77 |
DisclosureSEC source: 0001127602-19-027574 · form4.xml · nonDerivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,854 F1 · price: Sale prices reported for the transactions reported here range from $63.9100 to $63.9150. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| August 28, 2019 Filed Aug 29, 2019 20:42 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 4,908 | $23.76 | $116,589.54 |
DisclosureSEC source: 0001127602-19-027574 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2019 Filed May 10, 2019 21:17 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 11,848 | $0.00 Strike: $66.07 | $0.00 |
DisclosureSEC source: 0001127602-19-018175 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,848 Underlying: Common Stock · 11,848 shares Expires 2029-05-08 F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 8, 2019 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 8, 2020 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 08, 2019 Filed May 10, 2019 21:17 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 2,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018175 · form4.xml · derivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 Underlying: Common Stock · 2,270 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting. F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 07, 2019 Filed May 8, 2019 22:52 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-017792 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 7, 2019. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 7, 2019. Read SEC document |
| May 07, 2019 Filed May 8, 2019 22:52 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-017792 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-017243 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,283 Underlying: Common Stock · 2,283 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 9,496 | $0.00 Strike: $65.69 | $0.00 |
DisclosureSEC source: 0001127602-18-017243 · form4.xml · derivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,496 Underlying: Common Stock · 9,496 shares Expires 2028-05-09 F1 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from May 9, 2018 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 9, 2019 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:11 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 2,241 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-016988 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,241 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 8, 2018. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 8, 2018. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:11 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,241 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-016988 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. Read SEC document |
| May 10, 2017 Filed May 12, 2017 22:10 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 2,241 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-018000 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 10, 2017 Filed May 12, 2017 22:10 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 10,376 | $0.00 Strike: $66.92 | $0.00 |
DisclosureSEC source: 0001127602-17-018000 · form4.xml · derivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,376 Underlying: Common Stock · 10,376 shares Expires 2027-05-10 F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:53 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 1,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-017800 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 9, 2017. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 9, 2017. Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:53 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-017800 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. Read SEC document |
| May 11, 2016 Filed May 13, 2016 23:38 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,321 | $0.00 Strike: $83.90 | $0.00 |
DisclosureSEC source: 0001127602-16-052223 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,321 Underlying: Common Stock · 7,321 shares Expires 2026-05-11 F3 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 11, 2016 Filed May 13, 2016 23:38 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 1,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-052223 · form4.xml · derivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,787 Underlying: Common Stock · 1,787 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting. F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2016 Filed May 10, 2016 20:28 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 1,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-051671 · form4.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,466 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 6, 2016. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 6, 2016. Read SEC document |
| May 06, 2016 Filed May 10, 2016 20:28 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-051671 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock. Read SEC document |
| May 06, 2015 Filed May 7, 2015 21:14 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 5,167 | $0.00 Strike: $102.27 | $0.00 |
DisclosureSEC source: 0001179110-15-007267 · edgar.xml · derivative · entry 4 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,167 Underlying: Common Stock · 5,167 shares Expires 2025-05-06 F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2015 Filed May 7, 2015 21:14 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 1,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-15-007267 · edgar.xml · derivative · entry 3 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,466 Underlying: Common Stock · 1,466 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 05, 2015 Filed May 7, 2015 21:14 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 1,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-15-007267 · edgar.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F4 · derivative.exercise_date: 100% of the restricted stock units vested on May 5, 2015. F4 · derivative.expiration_date: 100% of the restricted stock units vested on May 5, 2015. Read SEC document |
| May 05, 2015 Filed May 7, 2015 21:14 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-15-007267 · edgar.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| February 06, 2015 Filed Feb 10, 2015 21:30 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | PurchaseCommon Stock | 10,000 | $99.92 | $999,150.00 |
DisclosureSEC source: 0001179110-15-002231 · edgar.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,173 Read SEC document |
| May 07, 2014 Filed May 9, 2014 00:46 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 4,868 | $0.00 Strike: $78.77 | $0.00 |
DisclosureSEC source: 0001179110-14-008010 · edgar.xml · derivative · entry 4 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,868 Underlying: Common Stock · 4,868 shares Expires 2024-05-07 F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 07, 2014 Filed May 9, 2014 00:46 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 1,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-14-008010 · edgar.xml · derivative · entry 3 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,904 Underlying: Common Stock · 1,904 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2014 Filed May 9, 2014 00:46 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 2,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-14-008010 · edgar.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F4 · derivative.exercise_date: 100% of the restricted stock units vested on May 6, 2014. F4 · derivative.expiration_date: 100% of the restricted stock units vested on May 6, 2014. Read SEC document |
| May 06, 2014 Filed May 9, 2014 00:46 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-14-008010 · edgar.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 10, 2013 Filed May 14, 2013 22:24 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 5,852 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-13-008387 · edgar.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,863 Underlying: Common Stock · 5,852 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 10, 2013, at the end of the first year of service. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 10, 2013, at the end of the first year of service. Read SEC document |
| May 10, 2013 Filed May 14, 2013 22:24 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 5,852 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-13-008387 · edgar.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 08, 2013 Filed May 10, 2013 23:37 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 2,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-13-008236 · edgar.xml · derivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,715 Underlying: Common Stock · 2,863 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2014, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2014, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.